Your browser doesn't support javascript.
loading
PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma.
Giuliani, Virginia; Miller, Meredith A; Liu, Chiu-Yi; Hartono, Stella R; Class, Caleb A; Bristow, Christopher A; Suzuki, Erika; Sanz, Lionel A; Gao, Guang; Gay, Jason P; Feng, Ningping; Rose, Johnathon L; Tomihara, Hideo; Daniele, Joseph R; Peoples, Michael D; Bardenhagen, Jennifer P; Geck Do, Mary K; Chang, Qing E; Vangamudi, Bhavatarini; Vellano, Christopher; Ying, Haoqiang; Deem, Angela K; Do, Kim-Anh; Genovese, Giannicola; Marszalek, Joseph R; Kovacs, Jeffrey J; Kim, Michael; Fleming, Jason B; Guccione, Ernesto; Viale, Andrea; Maitra, Anirban; Emilia Di Francesco, M; Yap, Timothy A; Jones, Philip; Draetta, Giulio; Carugo, Alessandro; Chedin, Frederic; Heffernan, Timothy P.
Afiliación
  • Giuliani V; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. VGiuliani@mdanderson.org.
  • Miller MA; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Liu CY; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hartono SR; Department of Molecular and Cellular Biology and Genome Center, University of California, Davis, CA, USA.
  • Class CA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Bristow CA; Department of Pharmaceutical Sciences, Butler University, Indianapolis, IN, USA.
  • Suzuki E; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Sanz LA; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Gao G; Department of Molecular and Cellular Biology and Genome Center, University of California, Davis, CA, USA.
  • Gay JP; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Feng N; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rose JL; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tomihara H; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Daniele JR; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Peoples MD; Department of Surgery, Kindai University Nara Hospital, Nara, JP, USA.
  • Bardenhagen JP; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Geck Do MK; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Chang QE; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Vangamudi B; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Vellano C; ORBIT, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ying H; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Deem AK; Exo Therapeutics, Cambridge, MA, USA.
  • Do KA; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Genovese G; Department of Cellular and Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Marszalek JR; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kovacs JJ; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kim M; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Fleming JB; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Guccione E; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Viale A; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Maitra A; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Emilia Di Francesco M; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Yap TA; Division of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
  • Jones P; Department of Oncological Sciences and Pharmacological Sciences at Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Draetta G; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Carugo A; Sheikh Ahmed Bin Zayed Al Nahyan Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Chedin F; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Heffernan TP; Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Nat Commun ; 12(1): 4626, 2021 07 30.
Article en En | MEDLINE | ID: mdl-34330913
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Proteína-Arginina N-Metiltransferasas / Proteínas Represoras / Daño del ADN / ARN / Carcinoma Ductal Pancreático Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Proteína-Arginina N-Metiltransferasas / Proteínas Represoras / Daño del ADN / ARN / Carcinoma Ductal Pancreático Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido